VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 365 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,000 | – | 25 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 25 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | – | 25 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 25 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $1,000 | -50.0% | 25 | -77.9% | 0.00% | 0.0% |
| Q2 2016 | $2,000 | -33.3% | 113 | +352.0% | 0.00% | -50.0% |
| Q4 2015 | $3,000 | -82.4% | 25 | -73.4% | 0.00% | -80.0% |
| Q3 2015 | $17,000 | -46.9% | 94 | -35.6% | 0.01% | -44.4% |
| Q2 2015 | $32,000 | +33.3% | 146 | -14.6% | 0.02% | +20.0% |
| Q4 2014 | $24,000 | +9.1% | 171 | 0.0% | 0.02% | +7.1% |
| Q3 2014 | $22,000 | +10.0% | 171 | +5.6% | 0.01% | +16.7% |
| Q2 2014 | $20,000 | -9.1% | 162 | -4.7% | 0.01% | -14.3% |
| Q1 2014 | $22,000 | – | 170 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Capital Analysts, LLC | 7,350 | $439,309,000 | 0.18% |
| GOLDMAN SACHS GROUP INC | 2,996,127 | $179,078,000 | 0.07% |
| MUFG Americas Holdings Corp | 52,285 | $3,125,000 | 0.06% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 22,936 | $1,367,000 | 0.05% |
| GOLDMAN SACHS GROUP INC | 419,100 | $25,050,000 | 0.01% |
| AQR Capital Management | 35,829 | $2,141,000 | 0.01% |
| HSBC HOLDINGS PLC | 33,669 | $2,009,000 | 0.01% |
| GOLDMAN SACHS GROUP INC | 147,000 | $8,786,000 | 0.00% |
| NOMURA HOLDINGS INC | 6,000 | $359,000 | 0.00% |
| Twin Tree Management, LP | 455 | $27,000 | 0.00% |